ArticleAmerican journal of respiratory and critical care medicine2024
Association of Ground-Glass Opacities with Systemic Inflammation and Progression of Emphysema.
Abstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Characteristics Associated with Lung Function Trajectories: An Analysis of the SPIROMICS Cohort.Annals of the American Thoracic Society · 2025Article
- Do You Believe in Magic? Computed Tomography, Artificial Intelligence, and Chronic Obstructive Pulmonary Disease.American journal of respiratory and critical care medicine · 2025Article
- Reply to ZhangAmerican journal of respiratory and critical care medicine · 2025Article
- Assessing the Correlation between Systemic Inflammation and Ground-Glass Opacities: Beyond a Single Indicator.American journal of respiratory and critical care medicine · 2025Article
- Respiratory Exacerbations and Lung Function Decline in People with Smoking History and Normal Spirometry.American journal of respiratory and critical care medicine · 2025Article
- Comparison of surgical trauma between three endoscopic thyroidectomy approaches and open surgery.Frontiers in oncology · 2025Article
- Ground-Glass Opacities on Computed Tomography of the Thorax to Predict Progression of Emphysema: Are We There Yet?American journal of respiratory and critical care medicine · 2024Article
Corrections and comments
- Commented on by
Authors and funding
26 authors.
Spyridon FortisCenter for Access & Delivery Research & Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, Iowa.ORCID 0000-0001-7807-6740
Junfeng GuoRoy J. Carver Department of Biomedical Engineering and.
Prashant NagpalDepartment of Radiology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin.
Muhammad F A ChaudharyRoy J. Carver Department of Biomedical Engineering and.
John D NewellRoy J. Carver Department of Biomedical Engineering and.
Sarah E GerardRoy J. Carver Department of Biomedical Engineering and.
MeiLan K HanDivision of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan.
Ella A KazerooniDivision of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan.
Fernando J MartinezDepartment of Medicine and.
Igor Z BarjaktarevicDivision of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California.
R Graham BarrDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York.
Sandeep BodduluriUniversity of Alabama at Birmingham Lung Imaging Lab, Division of Pulmonary, Allergy and Critical Care Medicine, and.
Robert PaineDivision of Respiratory, Critical Care and Occupational Medicine, Department of Internal Medicine, and.
Hira A AwanRoy J. Carver Department of Biomedical Engineering and.
Joyce D SchroederDepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah.
Lisa D Gravens-MuellerGillings School of Global Public Health.
Victor E OrtegaDivision of Respiratory Medicine, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona.
Wayne H AndersonDivision of Pulmonary and Critical Care Medicine, Marsico Lung Institute, and.
Christopher B CooperDivision of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California.
David CouperDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Prescott G WoodruffDepartment of Medicine, University of California, San Francisco, San Francisco, California; and.
Russell P BowlerDepartment of Medicine, National Jewish Medical and Research Center, Denver, Colorado.ORCID 0000-0003-4651-363X
Surya P BhattUniversity of Alabama at Birmingham Lung Imaging Lab, Division of Pulmonary, Allergy and Critical Care Medicine, and.
Eric A HoffmanDivision of Pulmonary, Critical Care and Occupational Medicine, Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine.ORCID 0000-0001-8456-9437
Joseph M ReinhardtRoy J. Carver Department of Biomedical Engineering and.
Alejandro P ComellasDivision of Pulmonary, Critical Care and Occupational Medicine, Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine.ORCID 0000-0003-1521-7520
Funding
Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Jon C.D. Houtman · 2000 to 2026
$70.0MPulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5MSPIROMICS II: Biological underpinnings of COPD heterogeneity and progressionU01HL137880 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WOODRUFF, PRESCOTT G · 2017 to 2021
$27.9MSPIROMICS GIC SupportU24HL141762 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID J, O'NEAL, WANDA K · 2018 to 2022
$7.2MMentoring Research in Precision Medicine for Lung DiseaseK24HL137013 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRESCOTT G WOODRUFF · 2017 to 2026
$1.2MAstraZenecaBayerBoehringer-Ingelheim Pharmaceuticals, Inc.Chiesi Farmaceutici S.p.A.COPD FoundationFoundation for the NIHGlaxoSmithKlineIkaria, Inc.MedImmuneMylanNCI NIH HHS P30 CA086862NHLBI NIH HHS HHSN268200900013CNHLBI NIH HHS HHSN268200900014CNHLBI NIH HHS HHSN268200900015CNHLBI NIH HHS HHSN268200900016CNHLBI NIH HHS HHSN268200900017CNHLBI NIH HHS HHSN268200900018CNHLBI NIH HHS HHSN268200900019CNHLBI NIH HHS HHSN268200900020CNHLBI NIH HHS K24 HL137013NHLBI NIH HHS U01 HL137880NHLBI NIH HHS U24 HL141762NIEHS NIH HHS P30 ES005605Novartis Pharmaceuticals CorporationRegeneron Pharmaceuticals, Inc.SanofiSunovionTakeda Pharmaceutical CompanyTheravance Biopharma
Abstract
PubMed holds no abstract for this paper.
Indexed as
Disease ProgressionInflammationPulmonary EmphysemaTomography, X-Ray ComputedAgedFemaleHumansLungMaleMiddle AgedPulmonary Disease, Chronic ObstructiveSpirometrychronic obstructive pulmonary diseaseemphysemaground-glass opacityinflammation
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.